IMNM Competitors & Alternatives
Compare Immunome Inc with similar stocks in the same industry
Biotechnology
IMNM
Main Stock$22.78
Tradestie Score
64
Market Cap
$987.09M
Revenue Growth
-1.0%
Analyst Upside
+57.0%
Top Competitors
230 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
APLS
Apellis Pharmaceuticals, Inc. Common Stock
|
$41.03
|
$2.92B | 38.3 | 59 | Compare |
|
RARE
Ultragenyx Pharmaceutical Inc.
|
$32.17
|
$2.89B | - | 59 | Compare |
|
IMVT
Immunovant, Inc. Common Stock
|
$38.79
|
$2.85B | - | 65 | Compare |
|
CPRX
Catalyst Pharmaceutical Inc.
|
$31.49
|
$2.56B | 18.2 | 59 | Compare |
|
CDTX
Cidara Therapeutics, Inc.
|
$221.38
|
$2.44B | - | 57 | Compare |
|
BEAM
Beam Therapeutics Inc. Common Stock
|
$31.15
|
$2.44B | - | 55 | Compare |
|
TARS
Tarsus Pharmaceuticals, Inc. Common Stock
|
$56.11
|
$2.42B | - | 48 | Compare |
|
BLTE
Belite Bio, Inc American Depositary Shares
|
$147.00
|
$2.41B | - | 57 | Compare |
|
IDYA
IDEAYA Biosciences, Inc. Common Stock
|
$36.61
|
$2.40B | - | 57 | Compare |
|
FOLD
Amicus Therapeutics, Inc
|
$14.49
|
$2.38B | - | 60 | Compare |
More IMNM Analysis
Data updated: Jul 14, 2026 | Industry: Biotechnology (SIC 2834)
230 stocks in this industry